4//SEC Filing
Lai Quintin J 4
Accession 0001562180-22-002665
CIK 0000105770other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 11:16 AM ET
Size
26.3 KB
Accession
0001562180-22-002665
Insider Transaction Report
Form 4
Lai Quintin J
VP Corp Development & Strategy
Transactions
- Exercise/Conversion
Common Stock
2022-03-14$94.27/sh+2,440$230,019→ 7,811.842 total - Sale
Common Stock
2022-03-14$371.89/sh−600$223,132→ 9,411.842 total - Sale
Common Stock
2022-03-14$374.45/sh−2,940$1,100,881→ 5,571.842 total - Sale
Common Stock
2022-03-14$370.94/sh−446$165,441→ 10,011.842 total - Sale
Common Stock
2022-03-14$374.92/sh−200$74,984→ 5,371.842 total - Exercise/Conversion
Common Stock
2022-03-14$83.47/sh+5,576$465,429→ 13,387.842 total - Sale
Common Stock
2022-03-14$369.86/sh−1,254$463,801→ 10,457.842 total - Sale
Common Stock
2022-03-14$372.92/sh−900$335,632→ 8,511.842 total - Exercise/Conversion
Stock Options (Right to buy)
2022-03-14−5,576→ 29,064 totalExercise: $83.47From: 2018-02-21Exp: 2027-02-21→ Common Stock (5,576 underlying) - Sale
Common Stock
2022-03-14$367.12/sh−1,271$466,604→ 12,116.842 total - Sale
Common Stock
2022-03-14$367.94/sh−405$149,017→ 11,711.842 total - Exercise/Conversion
Stock Options (Right to buy)
2022-03-14−2,440→ 34,640 totalExercise: $94.27From: 2018-02-05Exp: 2027-02-05→ Common Stock (2,440 underlying)
Footnotes (7)
- [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $366.50 to $367.42, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $367.56 to $368.22, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F3]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $369.40 to $370.36, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F4]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $370.41 to $371.32, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F5]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $371.65 to $372.40, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F6]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $372.70 to $373.46, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F7]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $373.86 to $374.83, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001744326
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 11:16 AM ET
- Size
- 26.3 KB